166 related articles for article (PubMed ID: 10637718)
1. Susceptibility testing and clinical effect of fusidic acid in oxacillin-resistant Staphylococcus aureus infections.
Liu CP; Lee CM; Su SC; Li YT
J Microbiol Immunol Infect; 1999 Sep; 32(3):194-8. PubMed ID: 10637718
[TBL] [Abstract][Full Text] [Related]
2. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney.
Gosbell IB; Mercer JL; Neville SA; Chant KG; Munro R
Pathology; 2001 May; 33(2):206-10. PubMed ID: 11358055
[TBL] [Abstract][Full Text] [Related]
3. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
Memikoğlu KO; Bayar B; Kurt O; Cokça F
Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
[TBL] [Abstract][Full Text] [Related]
4. Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus.
Lu CH; Chang WN
Clin Infect Dis; 2000 Sep; 31(3):723-7. PubMed ID: 11017822
[TBL] [Abstract][Full Text] [Related]
5. Rapid dissemination of Staphylococcus aureus with classic oxacillin resistance phenotype at a new university hospital.
Huang AH; Yan JJ; Wu JJ
J Hosp Infect; 2000 Apr; 44(4):309-15. PubMed ID: 10772838
[TBL] [Abstract][Full Text] [Related]
6. Immunoblot typing of oxacillin-resistant Staphylococcus aureus clinical isolates.
Pagani L; Debiaggi M; Garbagnoli P; Romero E
J Chemother; 1991 Jan; 3 Suppl 1():172-5. PubMed ID: 12041758
[TBL] [Abstract][Full Text] [Related]
7. [Staphylococcus aureus: new and old antimicrobial agents].
Perazzi B; Camacho M; Bombicino K; Flores Z; Vay C; Famiglietti A
Rev Argent Microbiol; 2010; 42(3):199-202. PubMed ID: 21186674
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
Bernard P; Jarlier V; Santerre-Henriksen A
Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
[TBL] [Abstract][Full Text] [Related]
9. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
10. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
[TBL] [Abstract][Full Text] [Related]
11. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
Peeters KA; Mascini EM; Blok HE; Sanders CJ
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
[TBL] [Abstract][Full Text] [Related]
12. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.
Ng J; Gosbell IB
J Antimicrob Chemother; 2005 Jun; 55(6):1008-12. PubMed ID: 15845784
[TBL] [Abstract][Full Text] [Related]
13. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci.
Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M
J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340
[TBL] [Abstract][Full Text] [Related]
14. Cefoxitin disk diffusion screen for confirmation of oxacillin-resistant Staphylococcus aureus isolates and utility in the clinical laboratory.
Sharp SE; Warren JA; Thomson RB
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):69-71. PubMed ID: 15629232
[TBL] [Abstract][Full Text] [Related]
15. Inducible clindamycin resistance in Staphylococcus aureus isolates causing bacteremia at a university hospital in southern Taiwan.
Janapatla RP; Yan JJ; Huang AH; Chen HM; Wu HM; Wu JJ
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):203-9. PubMed ID: 17300897
[TBL] [Abstract][Full Text] [Related]
16. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.
Dumitrescu O; Badiou C; Bes M; Reverdy ME; Vandenesch F; Etienne J; Lina G
Clin Microbiol Infect; 2008 Apr; 14(4):384-8. PubMed ID: 18261123
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
Tillotson GS; Draghi DC; Sahm DF; Tomfohrde KM; Del Fabro T; Critchley IA
J Antimicrob Chemother; 2008 Jul; 62(1):109-15. PubMed ID: 18397923
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic analysis of livestock oxacillin-resistant Staphylococcus aureus.
Hsieh JM; Chen RS; Tsai TY; Pan TM; Chou CC
Vet Microbiol; 2008 Jan; 126(1-3):234-42. PubMed ID: 17719189
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
20. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
